(Q45833400)

16 December 2017

title

Using controlled clinical trials to learn more about acute drug-induced liver injury (English)

1 reference

16 December 2017

author name string

Paul B Watkins

1

1 reference

16 December 2017

Paul J Seligman

2

1 reference

16 December 2017

John S Pears

3

1 reference

16 December 2017

Mark I Avigan

4

1 reference

16 December 2017

John R Senior

5

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

16 December 2017

published in

Hepatology

1 reference

16 December 2017

volume

48

1 reference

16 December 2017

page(s)

1680-1689

1 reference

16 December 2017

issue

5

1 reference

16 December 2017

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

cites work

1 reference

Isoforms of alanine aminotransferases in human tissues and serum--differential tissue expression using novel antibodies

21 January 2018

1 reference

Troglitazone-induced liver failure: a case study

21 January 2018

1 reference

Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy

21 January 2018

1 reference

Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury

21 January 2018

1 reference

Differential expression of mouse hepatic transporter genes in response to acetaminophen and carbon tetrachloride

21 January 2018

1 reference

Insight into hepatotoxicity: The troglitazone experience

21 January 2018

1 reference

Updated definitions of healthy ranges for serum alanine aminotransferase levels

21 January 2018

1 reference

The spectrum of hepatotoxicity.

21 January 2018

1 reference

Outcome and prognostic markers in severe drug-induced liver disease

21 January 2018

1 reference

Nonalcoholic fatty liver disease

21 January 2018

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus

21 January 2018

1 reference

Liver injury during highly active antiretroviral therapy: the effect of hepatitis C coinfection

21 January 2018

1 reference

A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial

21 January 2018

1 reference

Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial

21 January 2018

1 reference

Idiosyncratic drug hepatotoxicity

21 January 2018

1 reference

Drug-induced hepatotoxicity.

21 January 2018

1 reference

Mechanisms of drug-induced liver disease

21 January 2018

1 reference

Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).

21 January 2018

1 reference

Whole-genome patterns of common DNA variation in three human populations

21 January 2018

1 reference

Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct

21 January 2018

1 reference

Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection

21 January 2018

1 reference

Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era

21 January 2018

1 reference

Hepatic dysfunction associated with troglitazone

21 January 2018

1 reference

7 January 2021

Lymphocyte loss and immunosuppression following acetaminophen-induced hepatotoxicity in mice as a potential mechanism of tolerance

1 reference

7 January 2021

Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period

1 reference

7 January 2021

Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic

1 reference

7 January 2021

The fluctuations of viral load and serum alanine aminotransferase levels in chronic hepatitis C

1 reference

7 January 2021

Nonalcoholic fatty liver disease

1 reference

7 January 2021

Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994

1 reference

7 January 2021

Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C

1 reference

7 January 2021

Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment

1 reference

7 January 2021

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

1 reference

7 January 2021

The need for better clinical trials

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.22633

1 reference

16 December 2017

release_ncekqgupzzce5d3js3h2pm4vau

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ncekqgupzzce5d3js3h2pm4vau

24 November 2022

mapped directly with Wikidata item

PubMed ID

18853438

1 reference

16 December 2017